FTRE — Fortrea Holdings Inc.
$23.83+0.85%
Last close: · regular session
Last 60 sessions
FTRE closed at $23.83 (+0.85%) on Oct 26, 2026. Float: 94.3M shares. Latest SEC filing: 8-K on Sep 30, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for FTRE in the TickerWise workspace.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 15,000
- Website: https://www.fortrea.com
Latest SEC filings for FTRE
Latest FTRE news
- Fortrea to Participate in Jefferies Global Healthcare Conference Read article
- Fortrea 与 Omico 携手，推进生物标志物导向的肿瘤药物开发 Read article
- Kolaborasi Fortrea dan Omico untuk Mendorong Pengembangan Obat Onkologi Berbasis Biomarker Read article
- Fortrea und Omico kooperieren zur Förderung der biomarkergestützten Entwicklung von Krebsmedikamenten Read article
- Collaboration entre Fortrea et Omico pour faire progresser le développement de médicaments oncologiques basés sur des biomarqueurs Read article
- Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy? Read article
- MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE) Head to Head Contrast Read article
- Fortrea (NASDAQ:FTRE) Reaches New 52-Week High – What’s Next? Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.